Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 3, 2012, Pages 187-196

  Wu, Yuni ^a,b,c   Xu, Youhua ^a,b,c   Shen, Yali ^a,b,c   Wang, Cuicui ^a,b,c   Guo, Gaili ^a,b,c   Hu, Tiantian ^a,b,c  

^a Key Laboratory of Developmental Diseases in Childhood   (China)

^b CHONGQING KEY LABORATORY OF PEDIATRICS   (China)

^c Technology Cooperation Center for Child Development and Disorders   (China)

Author keywords

Acute promyelocytic leukemia; Arsenic trioxide; Differentiation; HL 60 cell; Proliferation; Tetramethylpyrazine

Indexed keywords

ARSENIC TRIOXIDE; CD11B ANTIGEN; CD14 ANTIGEN; CYCLIN DEPENDENT KINASE 2; CYCLIN E; MYC PROTEIN; NITROBLUE TETRAZOLIUM; PROTEIN P27; TETRAMETHYLPYRAZINE;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84863339177     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500017     Document Type: Article

References (29)

1. Bruserud O, Gjertsen BT, Huang T. Induction of differentiation and apoptosis-a possible strategy in the treatment of adult acute myelogenous leukemia. Oncologist 2000; 5: 454-462.
2. Steinman RA. Cell cycle regulators and hematopoiesis. Oncogene 2002; 21: 3403-3413
3. Wang ZY. Arsenic compounds as anticancer agents. Cancer Chemother Pharmacol 2001; 48 (Suppl 1): S72-S76.
4. Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, et al. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 1999; 59: 1041-1048
5. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998; 339: 1341-1348
6. Chiu YK, Kwan CY. Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: cardiovascular effects and mechanisms of action. Acta Pharmacol Sin 2002; 23: 1057-1068
7. Ali BH, Al-Moundhri M, Eldin MT, Nemmar A, Al-Siyabi S, Annamalai K. Amelioration of cisplatin-induced nephrotoxicity in rats by tetramethylpyrazine, a major constituent of the Chinese herb Ligusticum wallichi. Exp Biol Med 2008; 233: 891-896
8. Zhang Z, Wei T, Hou J, Li G, Yu S, Xin W. Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes. Life Sci 2003; 72: 2465-2472
9. Yang XG, Jiang C. Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma. Chin Med J 2010; 123: 3206-3211
10. Fan K, Li ZM. Effect of tetramethylpyrazine on proliferation of HL-60 leukemic cells induced by vascular endothelial growth factor. J Clin Rehabilit Tissue Engin Res 2003; 72: 2472.
11. Kang HK, Suh JH, Lee JJ, Yoon SH, Hyun JW, Choi SW, et al. Induction of the differentiation of HL-60 promyelocytic leukemia cells by L-ascorbic acid. Free Radic Res 2003; 37: 773-779
12. Freire AC, de Assis CF, Frick AO, da Silva MP, Haun M, Aoyama H, et al. Influence of protein phosphatase inhibitors on HL60 cells death induction by dehydrocrotonin. Leuk Res 2003; 27: 823-829
13. Seo BR, Lee KW, Ha J, Park HJ, Choi JW, Lee KT. Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation. Carcinogenesis 2004; 25: 1387-1394
14. Hintz KK, Ren J. Tetramethylpyrazine elicits disparate responses in cardiac contraction and intracellular Ca2+ transients in isolated adult rat ventricular myocytes. Vascul Pharmacol 2003; 40: 213-217
15. Liang MJ, He LC, Yang GD. Screening, analysis and in vitro vasodilatation of effective components from Ligusticum Chuanxiong. Life Sci 2005; 78: 128-133
16. Sheu JR, Kan YC, Hung WC, Lin CH, Yen MH. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci 2000; 67: 937-947
17. Buolamwini JK. Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 2000; 6: 379-392
18. Dimitroulakos J, Thai S, Wasfy GH, Hedley DW, Minden MD, Penn LZ. Lovastatin induces a pronounced differentiation response in acute myeloid leukemias. Leuk Lymphoma 2000; 40: 167-178
19. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11: 211-219
20. Morgan DO. Principles of CDK regulation. Nature 1995; 374: 131-134
21. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582
22. Ponzielli R, Katz S, Barsyte-Lovejoy D, Penn LZ. Cancer therapeutics: targeting the dark side of Myc. Eur J Cancer 2005; 41: 2485-2501
23. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K, Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential downregulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 2002; 99: 2199-2206
24. Huang MJ, Cheng YC, Liu CR, Lin S, Liu HE. A smallmolecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp Hematol 2006; 34: 1480-1489
25. Cai X, Yu Y, Huang Y, Zhang L, Jia PM, Zhao Q, et al. Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells. Leukemia 2003; 17: 1333-1337
26. Antman KH. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 2001; 6 (Suppl 2): 1-2
27. Jakubowicz-Gil J, Paduch R, Piersiak T, Glowniak K, Gawron A, Kandefer-Szerszen M. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem Pharmacol 2005; 69: 1343-1350
28. Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 2005; 65: 3336-3346
29. Izdebska M, Grzanka A, Ostrowski M, Zuryn A, Grzanka D. Effect of arsenic trioxide (Trisenox) on actin organization in K-562 erythroleukemia cells. Folia Histochem Cytobiol 2009; 47: 453-459.